Rapid sales growth yields no guarantee of profitability in the cannabis space.
News & Analysis: Aurora Cannabis Inc.
One top analyst isn't as bullish about this top pot stock as he was just three months ago. And it makes no sense.
Curaleaf is buying expansion with its $875 acquisition of Grassroots. Meanwhile, OrganiGram reported Q3 results, and Aurora Cannabis had a good news/bad news week.
Merrill Lynch's recommendation cut is affecting investor sentiment on the company.
Analysts fear the marijuana company is burning through cash.
The summer doldrums continued on Wall Street despite many companies reporting earnings.
The buzz is beginning to wear off for the most popular cannabis stocks.
This company can help you cash in on the global marijuana boom.
Aurora's focus on medical marijuana patients and international expansion could put these three companies on its buyout radar.
Rapid sales growth won't save these popular pot stocks from another year of red ink.